Christine Vauthier

11.1k total citations · 2 hit papers
143 papers, 8.4k citations indexed

About

Christine Vauthier is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Christine Vauthier has authored 143 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Biomaterials, 46 papers in Pharmaceutical Science and 32 papers in Molecular Biology. Recurrent topics in Christine Vauthier's work include Nanoparticle-Based Drug Delivery (60 papers), Advanced Drug Delivery Systems (43 papers) and RNA Interference and Gene Delivery (19 papers). Christine Vauthier is often cited by papers focused on Nanoparticle-Based Drug Delivery (60 papers), Advanced Drug Delivery Systems (43 papers) and RNA Interference and Gene Delivery (19 papers). Christine Vauthier collaborates with scholars based in France, Italy and Brazil. Christine Vauthier's co-authors include Patrick Couvreur, Kawthar Bouchemal, Gilles Ponchel, Denis Labarre, Elias Fattal, Irene Bravo‐Osuna, Gillian Barratt, F. Puisieux, Cédric Chauvierre and Huguette Pinto‐Alphandary and has published in prestigious journals such as Nucleic Acids Research, Biomaterials and Advanced Drug Delivery Reviews.

In The Last Decade

Christine Vauthier

143 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanotechnology: Intelligent Design to Treat Complex Disease

2006 671 citations Patrick Couvreur, Christine Vauthier Pharmaceutical Research profile →
Methods for the Preparation and Manufacture of Polymeric Nanoparticles

2008 637 citations Christine Vauthier, Kawthar Bouchemal Pharmaceutical Research profile →

Peers

Countries citing papers authored by Christine Vauthier

Since Specialization

Citations

This map shows the geographic impact of Christine Vauthier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Vauthier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Vauthier more than expected).

Fields of papers citing papers by Christine Vauthier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Vauthier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Vauthier. The network helps show where Christine Vauthier may publish in the future.

Co-authorship network of co-authors of Christine Vauthier

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Vauthier. A scholar is included among the top collaborators of Christine Vauthier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Vauthier. Christine Vauthier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining Endocytic Pathways of Fucoidan-Coated PIBCA Nanoparticles from the Design of their Surface Architecture 2022 ·Pharmaceutical Research ·Mariane Cajubá de Britto Lira Nogueira, (unknown), Valérie Nicolas, Nereide Stela Santos-Magalhães, Christine Vauthier	14
2	Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona 2017 ·International Journal of Pharmaceutics ·(unknown), Elquio Eleamen Oliveira, Christine Vauthier	37
3	Microemulsion systems containing bioactive natural oils: an overview on the state of the art 2016 ·Drug Development and Industrial Pharmacy ·Francisco Humberto Xavier Júnior, Christine Vauthier, (unknown), Éverton do Nascimento Alencar, Eryvaldo Sócrates Tabosa do Egito	41
4	Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles 2015 ·Journal of Pharmaceutical Sciences ·(unknown), Socorro Espuelas, Christine Vauthier, Gilles Ponchel, Juan M. Irache	30
5	Design, characterisation, and bioefficiency of insulin–chitosan nanoparticles after stabilisation by freeze-drying or cross-linking 2015 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), A. Langlois, W. Bietiger, Carole Mura, C. Péronet, (unknown), Diane Julien-David, Mengmeng Zhao, M. Pinget, N. Jeandidier, Christine Vauthier, Eric Marchioni, Yves Frère, S. Sigrist	67
6	Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 2014 ·Journal of Controlled Release ·Sabrina Valetti, Federica Maione, Simona Mura, Barbara Stella, Didier Desmaële, Magali Noiray, Juliette Vergnaud, Christine Vauthier, Luigi Cattel, Enrico Giraudo, Patrick Couvreur	49
7	HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles 2012 ·Journal of Chromatography B ·Khair Alhareth, Christine Vauthier, Claire Gueutin, Gilles Ponchel, Fathi Moussa	61
8	Scale-up of Nanoemulsion Produced by Emulsification and Solvent Diffusion 2012 ·Journal of Pharmaceutical Sciences ·Khalil Mitri, Christine Vauthier, Nicolas Huang, (unknown), Catherine Ringard-Lefebvre, Cecilia Anselmi, Moncef Stambouli, Véronique Rosilio, (unknown), Kawthar Bouchemal	27
9	Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP) 2012 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Christine Vauthier	16
10	Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery 2010 ·Acta Biomaterialia ·S. Sajeesh, Christine Vauthier, Claire Gueutin, Gilles Ponchel, Chandra P. Sharma	69
11	Artificial oxygen carrier based on polysaccharides–poly(alkylcyanoacrylates) nanoparticle templates 2010 ·Biomaterials ·Cédric Chauvierre, Romila Manchanda, Denis Labarre, Christine Vauthier, Michael C. Marden, (unknown)	24
12	Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin 2010 ·Journal of Controlled Release ·S. Sajeesh, Kawthar Bouchemal, Véronique Marsaud, Christine Vauthier, Chandra P. Sharma	112
13	Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface 2007 ·International Journal of Pharmaceutics ·Irene Bravo‐Osuna, Donato Teutonico, Silvia Arpicco, Christine Vauthier, (unknown)	75
14	Development of a Novel Vaccine Delivery System Based on Gantrez Nanoparticles 2006 ·Journal of Nanoscience and Nanotechnology ·Sara Gómez, Carlos Gamazo, Beatriz San Román, Christine Vauthier, Marta Ferrer, Juan M. Irache	39
15	PEGylation of microspheres for therapeutic embolization: Preparation, characterization and biological performance evaluation 2006 ·Biomaterials ·(unknown), Michel Bessodes, (unknown), Christine Vauthier, Daniel Scherman, Jean‐Claude Chaumeil	19
16	Insulin-loaded W/O/W multiple emulsions: comparison of the performances of systems prepared with medium-chain-triglycerides and fish oil 2004 ·European Journal of Pharmaceutics and Biopharmaceutics ·Fabienne Cournarie, (unknown), Véronique Rosilio, (unknown), Christine Vauthier, Jean–Louis Grossiord, M. Seiller	72
17	Novel Polysaccharide-Decorated Poly(Isobutyl Cyanoacrylate) Nanoparticles 2003 ·Pharmaceutical Research ·Cédric Chauvierre, Denis Labarre, Patrick Couvreur, Christine Vauthier	92
18	Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats 2002 ·International Journal of Pharmaceutics ·Fabienne Cournarie, Daniel Auchère, Didier Chevenne, Bernard Lacour, M. Seiller, Christine Vauthier	27
19	Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization 1999 ·International Journal of Pharmaceutics ·(unknown), F. Puisieux, Patrick Couvreur, Christine Vauthier	31
20	Capillary electrophoresis monitoring of the competitive adsorption of albumin onto the orosomucoid‐coated polyisobutylcyanoacrylate nanoparticles 1994 ·Electrophoresis ·Jean‐Christophe Olivier, Myriam Taverna, Christine Vauthier, Patrick Couvreur, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact